Working with the NHS
![Close-up of the hands of a nurse as she holds the right hand of a unseen older seated patient](/media/4jjjp5uc/nurse-comfort-patient-2522x722-banner-webp60.webp?width=968&height=457&rnd=133046126385700000)
The UK should aspire to nothing less than a health and care system that delivers the best patient outcomes in the world. We believe that a strong partnership between NHS and industry is the best way to improve outcomes for patients now and in the future.
Together we can:
- Deliver projects that improve patient outcomes, create efficiencies within the NHS and reduce health inequalities for people across the UK
- Create an innovation-ready NHS that can embrace new approaches to prevention and treatment
- Make the best use of data to enhance NHS research capability, generate real world evidence and allow new ways of working that help improve the patient experience and free up staff time
Collaborations allow companies and the NHS to pool skills, experience and resources to deliver projects that support the appropriate use of medicines in line with local or national guidance.
These projects provide a triple win, benefiting patients, the NHS and the companies – by improving patient care or helping the NHS as their primary objective.
Explore our case study library to find out more about different types of partnerships that are contributing to better patient care, a more efficient NHS, or both.
Disclosure and transparency
As a commitment to open, ethical ways of working, pharmaceutical companies publicly disclose the transfers of values made to healthcare professionals and organisations, patient groups, and certain members of the public.
Where relevant, values related to activities with healthcare professionals (and other relevant persons) and healthcare organisations are disclosed via the public, searchable database Disclosure UK.
Values related to partnerships with patient organisations and certain members of public, including patients, are published on individual company websites, and signposted within Disclosure UK.
The ABPI Code of Practice lays out comprehensive disclosure requirements for pharmaceutical companies. For more information about Disclosure UK and to search the database, visit www.disclosureuk.org.uk. Disclosure UK publishes three years of information. Values for each calendar year are published in June of the following year.
NHS publications
-
Unlocking access to future ATMPs in the UK
This report seeks to bring the end-to-end ATMP pathway to life, by recognising the breadth of the ecosystem that needs to function for the UK to fulfil its potential as a global leader in ATMPs, and the interconnectivity between its different elements.
-
Accelerating transformation: How to develop effective NHS-industry partnerships
The NHS Confederation and the ABPI have created new guidance on how to create effective NHS-industry partnerships. It was created with the expertise of more than 30 NHS and industry leaders.
-
NHS Confederation and the ABPI: Collaborate to innovate
This report sets out insights from a discussion between the NHS Confederation, the ABPI and health, industry and charity leaders. It explores how to maximise the potential of collaboration between the NHS, health charities and the life sciences industry to boost research and innovation in health.
-
Transforming lives, improving health outcomes: tackling the true cost of variation in uptake of innovative medicines
A new report from the NHS Confederation and ABPI has demonstrated the importance of the collaboration between industry and the NHS to improve patient outcomes across the UK.
-
PwC - Transforming lives, raising productivity
This report has been produced to understand the benefits of increased investment in clinically-and cost-effective innovative medicines to patients, society and the economy.
-
PwC - Transforming lives raising productivity - infographic
This infographic has been produced to understand the benefits of increased investment in clinically-and cost-effective innovative medicines to patients, society and the economy.
-
PwC - Transforming Lives and Raising Productivity Factsheet
These key messages have been produced to understand the benefits of increased investment in clinically-and cost-effective innovative medicines to patients, society and the economy.
-
Briefing paper: Embedding Research in the NHS – Cross sector Health and Care Bill briefing
The government has set an ambition for the UK to become the destination of choice for clinical research; an ambition shared by the UK’s research and life sciences community. We set out an opportunity to embed research within the NHS
-
NHS Confederation and ABPI: An examination of health inequalities in diabetes care in Leicester
The Leicester City CCG area has one of the highest prevalences of diabetes in England. Leaders in Leicester have invested significant resources in prioritising up-to-date, evidence-based approaches to treating diabetes.
-
NHS Confederation and ABPI: An examination of health inequalities in chronic obstructive pulmonary disease (COPD) care in the North West
Parts of the North West have some of the highest levels of COPD in England. Knowsley is the site of a national flagship programme to deliver respiratory services using a new community-focused care model.
-
NHS Confederation and ABPI: An examination of health inequalities in cancer care in Kent and Medway
The Kent and Medway Cancer Alliance brings together healthcare providers from across Kent and Medway, commissioners, hospices, patient representatives, voluntary and charitable organisations and the National Institute for Health Research, to transform the diagnosis, treatment and care for cancer patients.
-
Joint working
Joint Working projects aim to deliver ‘triple wins’ in the form of benefits to patients, the NHS and the pharmaceutical company or companies involved.